Abstract
Rare pancreatic endocrine tumors consisting of both exocrine and endocrine components have been reported sporadically. We investigated the ductal and acinar differentiation in pancreatic endocrine tumors. In immunohistochemical studies of 28 pancreatic endocrine tumors, staining with anti-carcinoembryonic antigen (CEA) or CA19-9 antibody indicated ductal differentiation, while staining with anti-amylase or anti-trypsin antibody indicated acinar differentiation. K-ras gene mutations and p53 gene alterations also were studied. Ten tumors were immunoreactive for CEA or CA19-9. Five tumors diffusely immunoreactive for CEA or CA19-9, in addition to endocrine markers, were diagnosed as duct–endocrine cell tumors of the pancreas. Two tumors diffusely immunoreactive for CEA or CA19-9 and also for pancreaticogut hormones as well as endocrine markers were diagnosed as duct–acinar–endocrine cell tumors. These tumors showed uniform histologic features and synchronous ductal, acinar, and endocrine differentiation, distinct from the coexisting different cellular populations seen in collision tumors. All tumors were malignant. These duct–endocrine cell tumors or duct–acinar–endocrine cell tumors of the pancreas may be derived from a stem cell that retains the capability of expressing either an exocrine or endocrine phenotype. Only one K-ras gene mutation and no p53 gene alterations were detected in these tumors, which suggests that they constitute an entity with a different origin than ductal carcinomas.
Similar content being viewed by others
REFERENCES
Chong FK, Graham JH, Madoff IM: Mucin producing carcinoid (“composite tumor”) of upper third of esophagus: a variant of carcinoid tumor. Cancer 44:1853–1859, 1979
Gould VE, Jao W, Chejfec G, Banner BF, Bonomi P: Neuroendocrine carcinomas of the gastrointestinal tract. Semin in Diagn Pathol 1:13–18, 1984
Soga J, Tazawa K, Aizawa O, Wada K, Tutu T: Argentaffin cell adenocarcinoma of the stomach: an atypical carcinoid? Cancer 33:999–1003, 1971
Bates HR, Belter LF: Composite carcinoid tumor (argentaffinoma-adenocarcinoma) of the colon. Dis Colon Rectum 10:467–470, 1967
Lyss AP, Thompson JJ, Gluck JH: Adenocarcinoid tumor of the colon arising in preexisting ulcerative colitis. Cancer 48:833–839, 1981
Cooper PH, Warkei RL: Ultrastructure of the goblet cell type of adenocarcinoid of the appendix. Cancer 42:2687–2695, 1978
Isaacson P: Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor). Am J Surg Pathol 5:213–224, 1981
Azzopardi JG, Pollock DJ: Argentaffin and argyrophil cells in gastric carcinoma. J Pathol Bacteriol 86:443–451, 1963
Ulich TR, Cheng L, Glover H, Yang K, Lewin KJ: A colonic adenocarcinoma with argentaffin calls: an immunoperoxidase study demonstrating the presence of numerous neuroendocrine products. Cancer 51:1483–1489, 1983
Klappenbach RS, Kurman RJ, Sinclair CF, James LP: Composite carcinoma-carcinoid tumors of the gastrointestinal tract: a morphologic, histochemical, and immunohistochemical study. Am J Clin Pathol 84:137–143, 1985
Kamisawa T, Fukayama M, Tabata I, Isawa T, Tsuruta K, Okamoto A, Koike M: Neuroendocrine differentiation in pancreatic duct carcinoma: special emphasis on duct-endocrine cell carcinoma of the pancreas. Path Res Pract 192:901–908, 1996
Kamisawa T, Fukayama M, Koike M, Tabata I, Okamoto A: A case of malignant cystic endocrine tumor of the pancreas. Am J Gastroenterol 82:86–89, 1987
Kamisawa T, Fukayama M, Koike M, Tabata I, Egawa N, Isawa T, Okamoto A, Hayashi Y: Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. Am J Gastroenterol 83:1118–1123, 1988
Brunetto MR, Randone A, Ranki M, Jalanko A, Piantino P, Giarin M, Capra G, Calvo PL, Pliveri F, Bonino F: Quantitative analysis of wild-type and HBeAg minus hepapitis B viruses by a sequence-dependent primer extension assay. J Med Virol 43:310–315, 1994
Mihas AA, Ceballos R, Mihas A, Gibson RG: Zollinger-Ellison syndrome associated with ductal adenocarcinoma of the pancreas. N Engl I Med 298:144–146, 1978
Tomita T, Bhatia P, Gourley W: Mucin producing islet cell adenoma. Hum Pathol 12:850–853, 1981
Eusebi V, Capella C, Bondi A, Sessa F, Vezzadini P, Mancini AM: Endocrine-paracrine cells in pancreatic exocrine carcinomas. Histopathology 5:599–613, 1981
Reid JD, Yuh S-L, Petrellli M, Jaffe R: Ductuloinsular tumors of the pancreas: a light, electron microscopic and immunohistochemical study. Cancer 49:908–915, 1982
Ordonez NG, Balsaver AM, Mackay B: Mucinous islet cell (amphicrine) carcinoma of the pancreas associated with watery diarrhea and hypokalemia syndrome. Hum Pathol 19:1458–1461, 1988
Kniffin WD, Spencer SK, Memoli VA, LeMarbre PJ: Metastatic islet cell amphicrine carcinoma of the pancreas: association with an eosinophilic infiltration of the skin. Cancer 62:1999–2004, 1988
Kashiwabara K, Nakajima T, Shinkai H, Fukuda T, Oono Y, Kurabayashi Y, Kojima T, Nagamachi Y: A case of malignant duct-islet cell tumor of the pancreas: immunohistochemical and cytofluorometric study. Acta Pathol Jpn 41:636–641, 1991
Arihiro K, Inai K: Malignant islet cell tumor of the pancreas with multiple hormone production and expression of CEA and CA19-9: report of an autopsy case. Acta Pathol Jpn 41:150–157, 1991
Ulich T, Cheng L, Lewin KJ: Acinar-endocrine cell tumor of the pancreas: report of a pancreatic tumor containing both zymogen and neuroendocrine granules. Cancer 50:2099–2105, 1982
Schron DS, Mendelsohn G: Pancreatic carcinoma with duct, endocrine, and acinar differentiation: a histologic, immunohistochemical, and ultrastructural study. Cancer 54:1766–1770, 1984
Chejfec G, Capella C, Solcia E, Jao W, Gould VE: Amphicrine cells, dysplasias, and neoplasias. Cancer 56:2683–2690, 1985
Nonomura A, Kono N, Mizukami Y, Nakanuma Y, Matsubara F: Duct-acinar-islet cell tumor of the pancreas. Ultrastruct Pathol 16:317–329, 1992
Hassan MO, Gogata PA: Malignant mixed exocrine-endocrine tumor of the pancreas with unusual intracytoplasmic inclusions. Ultrastruct Pathol 17:483–493, 1993
Klimstra DS, Rosai J, Heffess CS: Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 18:765–778, 1994
Okada Y, Mori H, Tsutsumi A: Duct-acinar-islet cell tumor of the pancreas. Pathol Int 45:669–676, 1995
Shimoike T, Goto M, Nakano I, Sato T, Migita Y, Ito T, Yanase T, Sezai S, Suzuki T, Nawata H: Acinar-islet cell carcinoma presenting as insulinoma. J Gastroenterol 32:830–835, 1997
Armed Forces Institute of Pathology: Tumors of the exocrine pancreas. In Tumors of Pancreas. J Rosai, LH Sobin (eds). Washington, DC, AFIP, 1997, pp 31–144
World Health Organization: Epithelial tumors. In Histological Classification of Tumours of the Exocrine Pancreas, Berlin, Springer, 1996, pp 11–21
Kerr-Conte J, Pattou F, Lecomte-Houcke M, Xia Y, Boilly B, Proye C, Lefebvre J: Ductal cyst formation in collagenembedded adult human islet preparations. A means to the reproduction of nesidioblastosis in vitro. Diabetes 45:1108–1114, 1996
Bouwen L, Blay ED: Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 44:947–951, 1996
Yuan S, Rosenberg L, Paraskevas S, Agapitos D, Duguid WP: Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61:67–75, 1996
Bouwens L, Lu WD, Krijger RD: Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398–404, 1997
Pour PM, Schmied B: The link between exocrine pancreatic cancer and the endocrine pancreas. Int J Pancreatol 25:77–87, 1999
Hruban RH, Mansfeld ADM, Offerhaus GJA, Weering DHJ, Allison DC, Goodman SN, Kencler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143:545–554, 1993
Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534–1543, 1993
Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus RN, Ito K, Aiyoshi Y, Kaplan EL: Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114:758–764, 1993
Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556–1560, 1994
Hoorens A, Lemonine NR, McLellan E, Morohoshi T, Kamisawa T, Heits PU, Stamm B, Ruschoff J, Wiedenmann B, Kloppel G: Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 143:685–698, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamisawa, T., Tu, Y., Egawa, N. et al. Ductal and Acinar Differentiation in Pancreatic Endocrine Tumors. Dig Dis Sci 47, 2254–2261 (2002). https://doi.org/10.1023/A:1020139328215
Issue Date:
DOI: https://doi.org/10.1023/A:1020139328215